Breach
Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports
Moderna (NASDAQ:MRNA), an mRNA medicines and preventive vaccine developer, closed at $202.63, down 17.57%. Reports of a possible leak of late-stage personalized melanoma vaccine data sent shares lower today. Investors are waiting for the planned full Phase 3 …
Read at Biztoc.com↗Headline from NewsAPI.